» Articles » PMID: 18323782

Distribution and Significance of Occult Intraepidermal Tumor Cells Surrounding Primary Melanoma

Overview
Publisher Elsevier
Specialty Dermatology
Date 2008 Mar 8
PMID 18323782
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Primary melanoma can recur at the excision site if not excised with a safety margin of surrounding uninvolved skin. To characterize the nature of residual melanoma in the skin surrounding primary tumors targeted by safety margins, we used array comparative genomic hybridization and fluorescent in situ hybridization to detect and spatially map aberrations in the skin adjacent to acral melanomas. Melanocytic cells with genetic amplifications in histopathologically normal skin (field cells) were detected exclusively in the epidermis in 84% of 19 cases, with a mean extension of 6.1 mm (in situ melanomas) and 4.5 mm (invasive melanomas) beyond the histopathological margin. Genetic profiling of these field cells indicated that they represent an early phase of disease preceding melanoma in situ. The extent of field cells did not correlate with tumor depth or diameter, indicating that tumor depth is not suited to predict the extent of field cells. These results demonstrate that, on acral sites, melanoma field cells extend significantly into seemingly normal skin. These field cells provide a plausible explanation for the tendency of certain melanoma types to recur locally despite apparently having undergone complete excision.

Citing Articles

The genetic evolution of acral melanoma.

Wang M, Fukushima S, Sheen Y, Ramelyte E, Cruz-Pacheco N, Shi C Nat Commun. 2024; 15(1):6146.

PMID: 39034322 PMC: 11271482. DOI: 10.1038/s41467-024-50233-z.


A Review of Contemporary Guidelines and Evidence for Wide Local Excision in Primary Cutaneous Melanoma Management.

Orme S, Moncrieff M Cancers (Basel). 2024; 16(5).

PMID: 38473257 PMC: 10930506. DOI: 10.3390/cancers16050895.


The genetic evolution of acral melanoma.

Wang M, Fukushima S, Sheen Y, Ramelyte E, Pacheco N, Shi C bioRxiv. 2023; .

PMID: 37904969 PMC: 10614839. DOI: 10.1101/2023.10.18.562802.


The Diagnosis and Management of Cutaneous Metastases from Melanoma.

Di Raimondo C, Lozzi F, Di Domenico P, Campione E, Bianchi L Int J Mol Sci. 2023; 24(19).

PMID: 37833981 PMC: 10572973. DOI: 10.3390/ijms241914535.


Melanoma pathology: new approaches and classification.

Yeh I, Bastian B Br J Dermatol. 2021; 185(2):282-293.

PMID: 34060071 PMC: 9292921. DOI: 10.1111/bjd.20427.


References
1.
Bastian B, Leboit P, Pinkel D . Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol. 2000; 157(3):967-72. PMC: 1885704. DOI: 10.1016/S0002-9440(10)64609-3. View

2.
Bastian B, Leboit P, Hamm H, Brocker E, Pinkel D . Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res. 1998; 58(10):2170-5. View

3.
Heenan P, Ghaznawie M . The pathogenesis of local recurrence of melanoma at the primary excision site. Br J Plast Surg. 1999; 52(3):209-13. DOI: 10.1054/bjps.1998.3050. View

4.
TREIDMAN L, McNEER G . Prognosis with local metastasis and recurrence in malignant melanoma. Ann N Y Acad Sci. 1963; 100:123-30. DOI: 10.1111/j.1749-6632.1963.tb57117.x. View

5.
Sauter E, Yeo U, Von Stemm A, Zhu W, Litwin S, Tichansky D . Cyclin D1 is a candidate oncogene in cutaneous melanoma. Cancer Res. 2002; 62(11):3200-6. View